MTA and Biodentine in Pulpotomized Primary Molars

Cristina Cuadros80 enrolled

Overview

The objective of the study is to evaluate and compare, clinically and radiographically,the effects of MTA and Biodentine when used as pulp dressings following pulpotomy in human primary molars.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

Conditions

Primary Molar Pulpotomy

Interventions

PulpotomyOTHER

Comparison of two different pulp dressing agents

PulpotomyOTHER

Comparison of two different pulp dressing agents

Eligibility

Sex: ALLMin age: 4 YearsMax age: 9 Years

Medical Language ↔ Plain English

Inclusion Criteria: * molars showing: 1. symptomless exposure of vital pulp by caries 2. no clinical or radiographic evidence of pulp degeneration (excessive bleeding from the root canal, internal root resorption, inter-radicular and/or furcal bone destruction) 3. the possibility of proper restoration of the teeth 4. no physiological resorption of more than one-third of the root Exclusion Criteria: * presence of systemic pathology and any history of allergic reaction to latex, local anaesthetics or to the constituents of the test pulp dressing agents

Locations (1)

Universitat Internacional de Catalunya

Sant Cugat del Vallès, Barcelona, Spain

Outcomes

Primary Outcomes

Number of molars with clinical success

Time frame: 12 months

Number of molars with radiographic success

Time frame: 6 and 12 months

Secondary Outcomes

Number of molars with no evidence of radicular radiolucency

Time frame: 6 and 12 months

Number of molars with no evidence of internal resorption

Time frame: 6 and 12 months

Number of molars with no evidence of external resorption

Time frame: 6 and 12 months

Number of molars with no evidence of furcation radiolucency

Time frame: 6 and 12 months

Number of molars with no symptoms of pain

Time frame: 6 and 12 months

Number of molars without swelling

Time frame: 6 and 12 months

Number of molars without fistulation

Time frame: 6 and 12 months

Number of molars without pathological mobility.

Time frame: 6 and 12 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.